FDA Plans Further Audits Of Telavancin Study Sites; No Major Problems To Date
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm says FDA and company audits of telavancin clinical trial data are progressing well; no predictions on how long process may take.